[HTML][HTML] The endocannabinoid system: a potential target for the treatment of various diseases

H Lowe, N Toyang, B Steele, J Bryant… - International journal of …, 2021 - mdpi.com
The Endocannabinoid System (ECS) is primarily responsible for maintaining homeostasis, a
balance in internal environment (temperature, mood, and immune system) and energy input …

CB1 and CB2 receptor pharmacology

AC Howlett, ME Abood - Advances in Pharmacology, 2017 - Elsevier
The CB 1 and CB 2 cannabinoid receptors (CB 1 R, CB 2 R) are members of the G protein-
coupled receptor (GPCR) family that were identified over 20 years ago. CB 1 Rs and CB 2 …

Endocannabinoid system components: overview and tissue distribution

N Joshi, ES Onaivi - Recent advances in cannabinoid physiology and …, 2019 - Springer
Marijuana/cannabinoid research has been transformed into mainstream science during the
last half-century. Evidence based research and remarkable biotechnological advances …

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

ES Onaivi, H Ishiguro, JP GONG, S Patel… - Annals of the New …, 2006 - Wiley Online Library
Two well‐characterized cannabinoid receptors (CBrs), CB1 and CB2, mediate the effects of
cannabinoids and marijuana use, with functional evidence for other CBrs. CB1 receptors are …

Peripheral cannabinoid receptor, CB2, regulates bone mass

O Ofek, M Karsak, N Leclerc, M Fogel… - Proceedings of the …, 2006 - National Acad Sciences
The endogenous cannabinoids bind to and activate two G protein-coupled receptors, the
predominantly central cannabinoid receptor type 1 (CB1) and peripheral cannabinoid …

[HTML][HTML] Targeting cannabinoid signaling in the immune system:“High”-ly exciting questions, possibilities, and challenges

A Oláh, Z Szekanecz, T Bíró - Frontiers in Immunology, 2017 - frontiersin.org
It is well known that certain active ingredients of the plants of Cannabis genus, ie, the
“phytocannabinoids”[pCBs; eg,(−)-trans-Δ9-tetrahydrocannabinol (THC),(−)-cannabidiol …

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

T Sugiura, S Kishimoto, S Oka, M Gokoh - Progress in lipid research, 2006 - Elsevier
2-Arachidonoylglycerol (2-AG) is a unique molecular species of monoacylglycerol isolated
in 1995 from rat brain and canine gut as an endogenous ligand for the cannabinoid …

Safety and efficacy of lenabasum in a phase II, randomized, placebo‐controlled trial in adults with systemic sclerosis

R Spiera, L Hummers, L Chung, TM Frech… - Arthritis & …, 2020 - Wiley Online Library
Objective To assess the safety and efficacy of lenabasum in diffuse cutaneous systemic
sclerosis (dc SS c). Methods A randomized, double‐blind, placebo‐controlled, phase II study …

[HTML][HTML] Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects

ES Onaivi, H Ishiguro, JP Gong, S Patel, PA Meozzi… - PLoS one, 2008 - journals.plos.org
Background Addiction and major depression are mental health problems associated with
stressful events in life with high relapse and reoccurrence even after treatment. Many …

Endocannabinoids and the regulation of their levels in health and disease

V Di Marzo, S Petrosino - Current opinion in lipidology, 2007 - journals.lww.com
Endocannabinoid levels appear to be transiently elevated as an adaptive reaction to re-
establish normal homeostasis when this is acutely and pathologically perturbed. In some …